SEC Form 4 · accession 0001209191-17-056617
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Lawrence
Officer — Chief, Bus. Ops & PAO
Period of report
Oct 9, 2017
Accepted (ET)
Oct 11, 2017 · 3:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 9, 2017 | S | 250 | $25.40 | D | 8,686 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sales pursuant to a 10b5-1 plan.